"Das Klinikum Stuttgart mit seinen drei Häusern Katharinenhospital, Krankenhaus Bad Cannstatt und Olgahospital bietet als Krankenhaus der Maximalversorgung umfassende medizinische Versorgung für die Menschen in Stuttgart und der Region Mittlerer Neckar. Träger der wirtschaftlich selbständigen gemeinnützigen Kommunalanstalt des öffentlichen Rechtes ist die Landeshauptstadt Stuttgart. Das Klinikum Stuttgart ist Akademisches Lehrkrankenhaus der Universität Tübingen mit direktem Zugang zu den neuesten wissenschaftlichen Erkenntnissen und Methoden in Diagnostik und Therapie."

During the past decade, Klinikum Stuttgart conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 3 clinical trials were completed, i.e. on average, 8.6% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 1 clinical trials were completed. i.e. 4.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Stuttgart" #1 sponsor was "University of Ulm" with 6 trials, followed by "GWT-TUD GmbH" with 3 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored, "Klinikum Stuttgart" with 3 trials sponsored and "Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Stuttgart" #1 collaborator was "University Hospital Freiburg" with 3 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Ardeypharm GmbH" with 1 trials as a collaborator and "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Stuttgart" are "Acute Myeloid Leukemia" (4 trials), "Acute Myeloid Leukemia (AML)" (4 trials), "Lymphoma" (4 trials), "COVID-19" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Klinikum Stuttgart" in a lesser frequency.

Most popular intervention types in "Klinikum Stuttgart" are "Drug" (34 trials), "Device" (9 trials), "Radiation" (9 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (6 trials), "Daunorubicin" (4 trials), "Placebo" (4 trials), "cyclophosphamide" (3 trials) and "doxorubicin hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Stuttgart" are 48 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Stuttgart". undefined are not yet recruiting, 14 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Klinikum Stuttgart, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Stuttgart, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".

Klinikum Stuttgart has several departments that took part in Clinical trials: "Klinik fuer Onkologie - Katharinenhospital Stuttgart" - 9 trials, "Department of Oncology / Clinical Center of Stuttgart" - 5 trials, "Olga-Hospital, Kinderklinik, Pädiatrisches Zentrum, Abt. Hämatologie/Onkologie" - 4 trials, "Katharinenhospital Stuttgart; Klinik für Hämatologie, Onkologie und Palliativmedizin" - 2 trials